Home / Stocks / Max Healthcare Ins Ltd
MAXHEALTH

Max Healthcare Ins Ltd Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹1,040.65

Change

+17.8 (1.74%)

Open

₹1,017.75

Prev. Close

₹1,022.85

Day High

₹1,040.65

Day Low

₹1,014.2

Volume Analysis

Traded

2,730,351

Delivered

1,754,662

Delivery %

64.27%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (1)

  • •Strong operating margin (27.0%)

Weaknesses (0)

No signal for this stock

Opportunities (1)

  • •Strong 3-year revenue growth (22.4%)

Threats (1)

  • •FII holding has been falling

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹1,075.91 ₹1,058.28 ₹1,049.46 ₹1,031.83 ₹1,023.01 ₹1,005.38 ₹996.56
Fibonacci ₹1,058.28 ₹1,048.18 ₹1,041.93 ₹1,031.83 ₹1,021.73 ₹1,015.48 ₹1,005.38
Camarilla ₹1,047.92 ₹1,045.5 ₹1,043.07 ₹1,031.83 ₹1,038.23 ₹1,035.8 ₹1,033.38

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

-0.83%

1 Week

+9.97%

1 Month

+26.92%

3 Months

+4.07%

6 Months

+1.7%

1 Year

-10.97%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

DuPont ROE Breakdown

10.52%

Net margin 15.1% × asset turnover 0.52x × equity multiplier 1.34x

Company Overview

Sector

Healthcare

Market Cap

₹99,557 Cr

P/E (TTM)

70.1

ROE

14.7%

Book Value

₹116.0

Face Value

₹10.0

Source: Screener.in (Consolidated figures) — data as of 19 Nov 2026. Not investment advice.

TopFund Analysis

Max Healthcare Ins Ltd holds up reasonably well on TopFund's composite fundamentals check within the Healthcare sector, at 67/100. The strongest factor is Financial Strength (98/100), while Valuation (1/100) is the weakest area to weigh before deciding. Notably: Strong operating margin (27.0%). FII holding has been falling.

TopFund Score — Fundamentals Quality

67/100 — Good

Data confidence: 78/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

98

Growth

82

Valuation

1

Cash Flow

75

Corporate Governance

51

Momentum

58

Institutional Ownership

77

Business Quality

78

Risk & Volatility

59

Liquidity

80

From Screener.in

  • −Stock is trading at 8.79 times its book value
  • −Company has a low return on equity of 13.7% over last 3 years.
  • −Company might be capitalizing the interest cost
  • −Dividend payout has been low at 13.6% of profits over last 3 years

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Transcript of Earnings Call held on November 3, 2026

Max Healthcare to participate in Goldman CIO Tour on Nov 13 and CITIC CLSA India Forum on Nov 17.

Audio recording of earnings call for Q2 and H1 FY2026 results available on website.

NCLT hearing in Kalinga Hospital matter adjourned to December 14, 2026.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales + 1,363 1,335 1,423 1,543 1,707 1,868 1,910 2,028 2,135 2,068 2,143 2,366 2,569
Expenses + 976 949 1,041 1,156 1,257 1,369 1,398 1,505 1,560 1,529 1,536 1,768 1,858
Operating Profit 387 386 382 387 451 499 512 523 575 538 606 598 711
OPM % 28.0% 29.0% 27.0% 25.0% 26.0% 27.0% 27.0% 26.0% 27.0% 26.0% 28.0% 25.0% 28.0%
Other Income + 45 46 45 35 41 -40 47 37 33 -3 48 41 41
Interest 9 11 21 24 34 52 55 55 54 60 67 71 74
Depreciation 58 61 70 77 84 98 101 104 108 111 123 132 138
Profit before tax 366 360 336 321 374 309 402 400 446 365 465 436 541
Tax % 24.0% 20.0% 25.0% 26.0% 25.0% 23.0% 21.0% 23.0% -10.0% 17.0% 26.0% 26.0% 23.0%
Net Profit + 277 289 252 236 282 239 319 308 491 301 342 323 414
EPS in Rs 3 3 3 2 3 2 3 3 5 3 4 3 4
Raw PDF — — — — — — — — — — — — —
YoY Sales growth 20 17 17 20 25 40 34 31 25 11 12 17 20

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2015 (S) Mar 2016 (S) Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 790 912 1,608 1,729 1,691 1,059 2,508 3,937 4,563 5,406 7,028 8,373 9,146
Expenses + 768 890 1,467 1,616 1,535 965 2,101 2,986 3,322 3,913 5,180 6,131 6,691
Operating Profit 22 22 141 113 156 94 407 951 1,241 1,493 1,849 2,243 2,455
OPM % 2.8% 2.5% 9.0% 7.0% 9.0% 9.0% 16.0% 24.0% 27.0% 28.0% 26.0% 27.0% 27.0%
Other Income + 33 35 59 65 56 48 -122 110 139 177 82 114 126
Interest 43 30 100 99 101 83 179 101 84 60 165 235 271
Depreciation 49 50 96 94 103 46 174 221 232 245 359 447 504
Profit before tax -38 -24 5 -15 8 13 -69 739 1,064 1,365 1,406 1,676 1,806
Tax % 0.0% 0.0% -236.0% 65.0% 102.0% -1.0% 67.0% 18.0% -4.0% 23.0% 24.0% 14.0% —
Net Profit + -38 -24 16 -25 0 59 -138 605 1,104 1,058 1,076 1,442 1,381
EPS in Rs -1 0 0 0 0 1 -1 6 11 11 11 15 14
Dividend Payout % 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 9.0% 14.0% 14.0% 13.0% —
Sales growth — 16 — 8 -2 -37 137 57 16 18 30 19 15

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2015 (S) Mar 2016 (S) Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Reserves 523 762 655 627 426 2,016 4,673 5,313 6,439 7,436 8,409 9,774 10,359
Borrowings + 296 273 874 981 1,003 875 1,101 913 689 1,299 3,010 3,478 3,795
Other Liabilities + 141 171 1,080 1,157 1,389 546 1,803 1,993 2,003 2,293 2,795 2,959 3,595
Total Liabilities 1,449 1,740 3,146 3,302 3,355 3,974 8,543 9,189 10,102 12,000 15,186 17,184 18,722
Fixed Assets + 430 424 2,244 2,227 2,192 851 6,536 7,018 7,039 8,784 11,502 12,991 13,966
CWIP 15 6 46 38 87 28 27 151 252 553 901 593 805
Investments 451 840 0 0 1 2,182 1 1 1 2 3 5 5
Other Assets + 554 469 856 1,036 1,075 913 1,980 2,020 2,810 2,661 2,781 3,595 3,946
Total Assets 1,449 1,740 3,146 3,302 3,355 3,974 8,543 9,189 10,102 12,000 15,186 17,184 18,722
Equity Capital 489 533 537 537 537 537 966 970 971 972 972 973 973

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2015 (S) Mar 2016 (S) Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 39 64 156 166 89 77 118 741 1,209 1,122 1,438 1,633
Cash from Investing Activity + -200 -330 -104 -124 -17 -2,641 206 -764 -1,187 -1,253 -1,593 -1,688
Cash from Financing Activity + 176 251 -48 -48 -74 2,353 191 -294 -289 -264 -163 59
Net Cash Flow 15 -16 4 -6 -2 -210 516 -317 -266 -395 -318 4
Free Cash Flow -15 42 41 100 -27 -13 1 192 877 342 500 165
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 223 338 135 166 75 89 15 89 110 93 95 89

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 23.75% → 23.71%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Public 3.99% 3.97% 3.91% 3.84% 3.77% 3.94% 4.09% 4.43% 4.52% 4.58% 4.55% 4.76%
Promoters 23.75% 23.75% 23.74% 23.74% 23.74% 23.74% 23.74% 23.74% 23.72% 23.71% 23.71% 23.71%
FII 60.69% 57.33% 56.99% 57.29% 56.93% 54.74% 54.76% 51.8% 50.55% 45.39% 41.78% 40.52%
DII 11.55% 14.96% 15.36% 15.14% 15.55% 17.59% 17.41% 20.03% 21.2% 26.32% 29.95% 31.01%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Max Healthcare Ins Ltd (this stock) 99,557 70.1 8.82 14.7%
Aurobindo Pharma Ltd 104,215 25.7 2.64 10.1%
Mankind Pharma Limited 108,424 46.5 6.16 13.1%
Lupin Limited 89,994 16.0 3.75 28.7%
Manipal Health Enterpri L 89,630 95.6 5.36 12.7%
Cipla Ltd 112,563 36.2 3.18 11.6%
Dr. Reddy S Laboratories 115,092 41.1 2.96 11.2%

Which Mutual Funds Hold Max Healthcare Ins Ltd?

Frequently Asked Questions about Max Healthcare Ins Ltd

Community Sentiment

What are other investors saying about Max Healthcare Ins Ltd?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.